Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
cisplatin, Quantity: 1 mg/mL
Accord Healthcare Pty Ltd
Injection, concentrated
Excipient Ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid
Intravenous
1
(S4) Prescription Only Medicine
Cisplatin Intas may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? Metastatic non-seminomatous germ cell carcinoma,? Advanced stage, refractory ovarian carcinoma,? Advanced stage, refractory bladder carcinoma,? Refractory squamous cell carcinoma of the head and neck
Visual Identification: A clear, colourless to pale yellow solution in an amber glass vial; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2018-07-09